Lab Seeks Approval to Import Obscure Synthetic Drug Substance
Published Date: 4/3/2026
Notice
Summary
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Import Registration Excludes Finished Dosage Forms
The notice says placement of these drug codes on the company's registration does not automatically approve later permits, and authorization will not extend to the import of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale. Permit approvals will only occur when activity is consistent with 21 U.S.C. 952(a)(2).
Importer Seeks to Supply Analytical Standards
On February 11, 2026, Lipomed/LGC Standards applied to be registered to import many Schedule I and II controlled substances (examples include 3-Fluoro-N-methylcathinone, cathinone, methcathinone, mephedrone, GHB, fentanyl-related compounds, LSD, psilocybin, and many others). The company says it plans to import analytical reference standards for distribution to its customers for research and analytics purposes.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
2026-05482 — Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!
Previous / Next Documents
Previous: 2026-06520 — Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Blue Rabbit Veterinary LLC wants to become an official importer of certain controlled drugs used in veterinary care. People and companies involved with these drugs can share their thoughts or ask for a hearing by May 4, 2026. This move could affect how these substances are brought into the U.S., but no costs or fees are mentioned yet.
Next: 2026-06522 — Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Research Triangle Institute wants to make large amounts of a controlled substance called tetrahydrocannabinols for research and testing. People who already make or use this drug can share their thoughts or ask for a hearing by June 2, 2026. This move could help scientists get better materials for their studies without changing any other drug rules.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in